All In Biotech

Drug Trial Radar · NCT03659448

Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

Multicenter, Open-label, Randomized, Controlled, Parallel Arms Clinical Study on Performance of SGM-101, a Fluorochrome-labeled Anti-CEA Monoclonal Antibody, for Delineation of Primary/Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

Last checked: Nov 19, 2026Latest source record: Apr 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Jun 17, 2019

Primary completion

Nov 2024

Study completion Dec 2024

Sponsor

Lead sponsor
SurgimabIndustry
Sponsor type
Industry
First posted
Sep 6, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The performance of SGM-101, an intraoperative imaging agent, will be compared to that of standard "white light" visualization during surgical resections of colorectal cancer.

Conditions

  • Colorectal Neoplasms

Interventions

  • SGM-101Drug

    A fluorochrome-labeled anti-carcinoembryonic antigen (CEA) monoclonal antibody intraoperative imaging agent.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Surgical resection histopathology.Time frame: Through completion of surgery, up to 9 weeks.

Locations

11 sites in 4 countries. Site status is shown where the registry gives one.

  • City of Hope National Medical Center

    Duarte, California · Recruiting

  • Moores Cancer Center - UCSD Health

    La Jolla, California · Recruiting

  • Cleveland Clinic Florida

    Weston, Florida · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Not yet recruiting

  • University of Massachusetts

    Worcester, Massachusetts · Recruiting

  • Perelman Center for Advanced Medicine

    Philadelphia, Pennsylvania · Recruiting

  • Universitätsmedizin Göttingen, Klinik für Allgemein- Viszeral- und Kinderchirurgie

    Göttingen, Germany · Recruiting

  • Fondazione IRCCS Policlinico San Matteo

    Pavia, Lombardy, Italy · Recruiting

  • Catharina Ziekenhuis Eindhoven

    Eindhoven, Netherlands · Recruiting

  • Leiden University Medical Center

    Leiden, Netherlands · Recruiting

  • Erasmus MC

    Rotterdam, Netherlands · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.